日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications

靶向代谢-表观遗传-免疫轴治疗癌症:分子机制及治疗意义

Wang, Xing; Luo, Xiyuan; Xiao, Ruiling; Liu, Xiaohong; Zhou, Feihan; Jiang, Decheng; Bai, Jialu; Cui, Ming; You, Lei; Zhao, Yupei

Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer.

癌细胞衍生的唾液酸化 IgG 与 Siglec-7/9/10 相互作用,是胰腺癌潜在的免疫治疗靶点。

Zhang Shenghua, Cui Ming, Huang Xinmei, Feng Xiaoyao, Xiao Ruiling, Liu Qijia, Bai Jialu, Han Xianlin, Liu Xiaoding, Xu Weiyan, Huang Jing, Liao Quan, Zhao Yupei, Qiu Xiaoyan

[Expression of Concern] c‑Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma

【关注事项】c-Fos/ERK促进胰腺上皮内瘤变向胰腺导管腺癌的进展

You, Lei; Ren, Xiaoxia; Du, Yongxing; Zhao, Wenjing; Cui, Ming; Chen, Ge; Zhao, Yupei

Intrathecal injection of rituximab inhibits microglial M1 polarisation to alleviate neuropsychiatric SLE symptoms via the cAMP/PKA/CREB signalling pathway

鞘内注射利妥昔单抗可通过 cAMP/PKA/CREB 信号通路抑制小胶质细胞 M1 极化,从而缓解系统性红斑狼疮 (SLE) 的神经精神症状。

Chunyan Li,Wang Yu,AnMao Li,Yong Chen,Jing Zhao,Yupei Lin,Xiao Li Pan,Mei Tian

Impact of precise preoperative vascular assessment and different dorsal pancreatic artery variant subtypes on pancreatic surgery-related bleeding

术前精确血管评估及不同背胰动脉变异亚型对胰腺手术相关出血的影响

Yang, Jinshou; Xu, Jiahao; Wang, Ming; Yin, Bohui; Yu, Hanyang; Jiang, Chenjun; Xu, Qiang; Zhao, Yupei

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

生理和病理状态下胰腺内分泌和外分泌信号传导及相互作用

Hu, Chenglin; Chen, Yuan; Yin, Xinpeng; Xu, Ruiyuan; Yin, Chenxue; Wang, Chengcheng; Zhao, Yupei

Proactive emergency laparoscopic cholecystectomy for complex acute cholecystitis: a prospective cohort at a national emergency center in China

中国某国家级急诊中心前瞻性队列研究:复杂性急性胆囊炎的主动急诊腹腔镜胆囊切除术

Liu, Qiaofei; Han, Xianlin; Zhang, Guannan; Huang, Hua; Chen, Shaobo; Wang, Hongyu; Ye, Xin; Wu, Xin; Lu, Junyang; Niu, Beizhan; Xu, Lai; Xiang, Qu; Liu, Wenjing; Lin, Chen; Tian, Feng; Xiao, Jianchun; Hua, Surong; Chen, Weijie; Wei, Yinxin; Hou, Rui; Sun, Mengqing; Hong, Xiafei; Wang, Mengyi; Cao, Zhe; Shao, Qianqian; Zhang, Ning; Wang, Xianze; Zhao, Bangbo; Gao, Junyi; Yang, Gang; Cong, Lin; Liu, Wei; Li, Binglu; Kleeff, Jorg; Zhang, Taiping; Wang, Weibin; Zhao, Yupei

FOLR2(+) macrophages in cancer: allies or enemies

癌症中的FOLR2(+)巨噬细胞:盟友还是敌人

Jiang, Decheng; Xiao, Ruiling; Bai, Jialu; Wang, Xing; Fang, Yuan; Liu, Jianzhou; Wang, Xiaohan; Cui, Ming; You, Lei; Zhao, Yupei

Novel paradigms in KRAS targeting: Unveiling strategies to combat drug resistance

KRAS靶向治疗的新范式:揭示对抗耐药性的策略

Luo, Xiyuan; Zhou, Feihan; Tang, Yuemeng; Liu, Xiaohong; Xiao, Ruilin; Gu, Minzhi; Bai, Jialu; Jiang, Decheng; Yang, Gang; You, Lei; Zhao, Yupei

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies

增强子重编程:在癌症中的关键作用及极具前景的治疗策略

Yang, Jinshou; Zhou, Feihan; Luo, Xiyuan; Fang, Yuan; Wang, Xing; Liu, Xiaohong; Xiao, Ruiling; Jiang, Decheng; Tang, Yuemeng; Yang, Gang; You, Lei; Zhao, Yupei